Literature DB >> 10721602

[Hyperbaric oxygenation therapy, basic concepts].

L García-Covarrubias1, E Cuauhtémoc Sánchez-Rodríguez.   

Abstract

Hyperbaric oxygen therapy (HBO) is defined as a treatment in which a patient breathes 100% oxygen in a pressurized environment of at least 1.4 absolute atmospheres. The first written reports data from the 15th century, when it was used to treat respiratory diseases. For some time its applications lacked scientific support until the second half of this century when scientific publications were carried out using current methodology. This type of therapy is grounded basically in three gas laws: Henry's Law, Dalton's Law and Boyle's Law. The beneficial effects are: wound healing enhancement; increased neutrophil bactericidal capacity; direct toxic effect against some microorganisms; arteriolar vasoconstriction with subsequent edema reduction and decreased ischemia/reperfusion injury, among others. These are the result of increased environmental pressure and high oxygen tension in body tissues. Currently there are 13 accepted conditions to be treated with HBO and others are still under investigation. Following UHMS-accepted treatment protocols, complications and/or adverse effects are limited.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721602

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  3 in total

1.  The Efficacy of Hyperbaric Oxygen Therapy on Middle Cerebral Artery Occlusion in Animal Studies: A Meta-Analysis.

Authors:  Yang Xu; Renjie Ji; Ruili Wei; Bo Yin; Fangping He; Benyan Luo
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

2.  Antioxidant Response of Chronic Wounds to Hyperbaric Oxygen Therapy.

Authors:  Antoni Sureda; Juan M Batle; Miquel Martorell; Xavier Capó; Silvia Tejada; Josep A Tur; Antoni Pons
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

3.  Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia.

Authors:  Qiang You; Lan Li; Su-Qin Xiong; Yu-Fen Yan; Dan Li; Na-Na Yan; Hong-Ping Chen; You-Ping Liu
Journal:  Front Aging Neurosci       Date:  2019-04-17       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.